As per MRFR analysis, the India Nano Biotechnology Market Size was estimated at 223.36 (USD Million) in 2023.The India Nano Biotechnology Market is expected to grow from 244.8(USD Million) in 2024 to 983.2 (USD Million) by 2035. The India Nano Biotechnology Market CAGR (growth rate) is expected to be around 13.473% during the forecast period (2025 - 2035).
Key India Nano Biotechnology Market Trends Highlighted
The Indian market for nanobiotechnology is expanding significantly due to a number of important factors. The growing need for personalised medicine and advanced medical therapies, which are at the forefront of research supported by both the public and private sectors, is one of the main factors propelling the market.
With programs like the Biotechnology Industry Research Assistance Council (BIRAC) and the Biotechnology Vision 2025, the government has been aggressively advancing biotechnology with the goal of making India a biotechnology leader on a worldwide scale.
Additionally, since India prioritises food security and sustainable agricultural methods, the development of agro-biotechnology for enhancing crop yields and insect resistance is becoming more and more significant.
Opportunities in the Indian nanobiotechnology market are growing, especially in the areas of biosensors and drug delivery systems. There is plenty of opportunity to investigate novel uses of nanotechnology in diagnostics and treatments due to the expanding healthcare industry and rising R&D expenditures.
Furthermore, in order to improve drug absorption and produce more potent therapies, the Indian pharmaceutical industry is quickly implementing nano-based technology. Collaborations between Indian academic institutions and industry actors have increased recently, according to trends.
These collaborations are crucial for turning scientific findings into useful applications, especially in the fields of agriculture and healthcare. Additionally, researchers are focussing on biodegradable nanomaterials to lessen their influence on the environment, as the nano-biotechnology industry places an increasing emphasis on ecologically sustainable practices.
The landscape of nanobiotechnology is anticipated to change as India develops its regulatory frameworks and encourages innovation, opening the door for new discoveries and uses.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
India Nano Biotechnology Market Drivers
Increasing Demand for Cancer Treatment Solutions
In India, the incidence of cancer has been on a steady rise, with the Indian Council of Medical Research (ICMR) reporting that approximately 1.5 million new cases were registered in 2023, and the number is projected to increase to 1.7 million by 2025.
This escalating demand for effective cancer treatment drives the growth of the India Nano Biotechnology Market, as nanobiotechnology offers innovative approaches for targeted drug delivery and personalized medicine.
Leading organizations such as the Tata Memorial Centre and the All India Institute of Medical Sciences are actively involved in research and clinical trials focused on nanobiotechnology solutions for cancer treatment. The interest from these established institutions reflects the growing recognition of nanotechnology's potential in improving treatment efficacy and patient outcomes.
Government Initiatives and Funding for Biotechnology
The Indian government has made significant strides in boosting the biotechnology sector through various initiatives. The Department of Biotechnology (DBT) under the Ministry of Science and Technology has been allocating substantial funds to promote research in nanobiotechnology.
For instance, the 'Biotechnology Startup Promotion Scheme' aims to foster innovation and support emerging biotech companies.
As a result, the funding and policy support create a favorable environment for the growth of the India Nano Biotechnology Market, enabling startups and established companies to invest in research and development (R&D) and accelerate the commercialization of nanobiotech-based applications.
Rising Investments in Nanotechnology Research
The landscape of the India Nano Biotechnology Market is significantly influenced by increasing investments in nanotechnology research. According to the National Association of Software and Service Companies (NASSCOM), major companies and research institutions invested over USD 300 million in nanotechnology-related R&D in 2022 alone.
Prominent organizations like the Indian Institute of Technology (IIT) and the Indian Institute of Science (IISc) are at the forefront of nanobiotechnology research, developing new applications in drug delivery systems and diagnostics. This influx of capital and innovation from established universities and research institutions enhances the potential of the nano biotechnology sector, contributing to market growth.
India Nano Biotechnology Market Segment Insights
Nano Biotechnology Market Application Insights
The Application segment of the India Nano Biotechnology Market plays a crucial role in revolutionizing various sectors, reflecting significant advancements in technology and innovation.
The market's focus on Pharmaceuticals highlights its pivotal importance, as nano-biotechnology enhances the development of novel drug delivery systems, improving the efficacy and safety of therapeutic agents while reducing side effects.
In the realm of Medical devices, the integration of nanotechnology leads to the creation of smarter, more efficient diagnostic tools and implants that provide better patient outcomes. The emphasis on Medical research showcases how nano-biotechnology is driving innovations in diagnostics and treatment methodologies, enabling researchers to explore new avenues for combating diseases more effectively.
In the Food and Agriculture sector, nanotechnology contributes to improved crop yields, enhanced nutrient delivery, and solutions for pest control, ultimately supporting food security initiatives.
This diversified focus within the Application segment underscores the growing significance of the India Nano Biotechnology Market, where developments are not only addressing current challenges but also shaping the future of healthcare, agriculture, and research industries.
Overall, the market exhibits a promising trajectory driven by rising investment from both public and private sectors, fostering an environment ripe for innovation and growth. Insights into this sector indicate that advancements in Nano Biotechnology are set to significantly impact the Indian economy and its global standing in scientific research and application.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Nano Biotechnology Market Therapeutics Insights
The Therapeutics segment of the India Nano Biotechnology Market is gaining significant attention and is poised for substantial growth, driven by advancements in nanotechnology that enhance the efficacy and delivery of medical treatments.
Within this segment, Dental therapies are increasingly important as they provide innovative solutions for oral diseases, leveraging nanomaterials to improve regeneration and healing processes. Cardiac therapies harness nanotechnology for targeted drug delivery and regenerative medicine, addressing the rising incidence of cardiovascular diseases in India.
Orthopedic therapies focus on using nanotechnology materials for enhanced bone repair and prosthetics, which is critical given the increasing number of orthopedic surgeries due to lifestyle-related issues. Additionally, the 'Others' segment includes various emerging applications that utilize nanotechnology in treating chronic illnesses and age-related conditions.
The rise in chronic diseases, along with a growing population and aging demographic, are favorable factors contributing to the expansion of the India Nano Biotechnology Market, as stakeholders seek innovative therapeutic solutions to improve patient outcomes.
With a robust Research and Development framework, India is positioned to emerge as a leader in the global market for therapeutic applications involving nanotechnology, thereby significantly influencing India Nano Biotechnology Market statistics and revenue.
India Nano Biotechnology Market Key Players and Competitive Insights
The India Nano Biotechnology Market is characterized by a rapidly evolving landscape, driven by innovations in nanotechnology and its applications across various sectors, including healthcare, agriculture, and environmental science. The competitive environment is enhanced by the presence of both established players and emerging startups dedicated to advancing nano-biotechnology solutions.
These companies are focusing on the development of novel products and technologies that leverage the unique properties of nanoparticles for enhanced efficacy and efficiency.
The integration of nanotechnology in biotechnology is fostering advancements in drug delivery systems, diagnostics, and therapeutic applications, leading to a robust ecosystem where companies continuously strive to enhance their market position through strategic collaborations and research initiatives.
Sartorius has carved a significant niche within the India Nano Biotechnology Market, focusing on bioprocessing and laboratory solutions. The company's strengths lie in its extensive portfolio that includes advanced process technology and effective bioprocessing solutions, which are essential for the development and manufacture of biopharmaceuticals.
Sartorius has established a strong presence through its commitment to innovation and quality, which resonates strongly with customers in the biotechnology sector. The company's focus on providing customizable solutions has cemented its reputation, enabling it to cater effectively to various segments within the Indian nano-biotechnology landscape.
Furthermore, Sartorius emphasizes research and development to ensure it stays at the forefront of technological advancements, making it a vital player in the industry. Intas Pharmaceuticals has positioned itself as a key player in the India Nano Biotechnology Market, focusing on formulations that leverage nano-biotechnology to enhance therapeutic delivery systems.
The company is renowned for its robust pipeline of biosimilars and novel drug formulations aimed at providing better treatment options for various medical conditions. Intas Pharmaceuticals has established a comprehensive market presence, driven by its commitment to quality, innovation, and customer-centric solutions.
The company’s strengths include its significant investment in research and development, which has enabled it to introduce several key products that utilize nanotechnology to improve drug stability and delivery.
Moreover, Intas Pharmaceuticals has pursued strategic mergers and acquisitions to bolster its capabilities and expand its market footprint, which further enhances its competitive edge in the Indian nano-biotechnology sector.
Key Companies in the India Nano Biotechnology Market Include:
India Nano Biotechnology Market Developments
The India Nano Biotechnology Market is witnessing significant growth with noted developments in recent months. In October 2023, Biocon announced advancements in its biopharmaceutical offerings focused on nanoparticle technology aimed at oncology treatments.
In September 2023, Sartorius expanded its product portfolio catering to nano-scale bioprocessing, enhancing its manufacturing capabilities in the region. Additionally, Zydus Cadila reported progress in developing biosimilars utilizing nanotechnology, contributing to the range of affordable healthcare options.
Moreover, Lupin Pharmaceuticals and Bharat Biotech are investing in Research and Development to innovate in vaccine delivery systems incorporating nanoparticle technologies. AstraZeneca India formed collaborations in August 2023 to advance ongoing research initiatives in nano-delivery systems that improve therapeutic efficacy.
When it comes to mergers and acquisitions, Dr. Reddy's Laboratories successfully integrated a tech-based firm in July 2023, enhancing its nanotechnology capabilities. The market continues to expand, driven by rising investments from both domestic and international players, improving healthcare solutions, thereby impacting patient outcomes positively across India.
India Nano Biotechnology Market Segmentation Insights
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 223.36(USD Million) |
| MARKET SIZE 2024 | 244.8(USD Million) |
| MARKET SIZE 2035 | 983.2(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 13.473% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Sartorius, Intas Pharmaceuticals, Zydus Cadila, Jubilant Life Sciences, Agilent Technologies, Dr Reddy's Laboratories, AstraZeneca India, Merck Group, IIL, Thermo Fisher Scientific, Torrent Pharmaceuticals, Bharat Biotech, Wockhardt, Lupin Pharmaceuticals, Biocon |
| SEGMENTS COVERED | Application, Therapeutics |
| KEY MARKET OPPORTUNITIES | Therapeutic applications in cancer treatment, Drug delivery system advancements, Agriculture enhancement through nano-solutions, Diagnostics and imaging innovations, Environmental remediation technologies. |
| KEY MARKET DYNAMICS | Favorable government policies, Increased R&D investments, Growing healthcare applications, Rising agricultural demand, Technological advancements in nanomaterials |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
In 2024, the India Nano Biotechnology Market is expected to be valued at 244.8 million USD.
By 2035, the market is projected to grow to 983.2 million USD.
The expected CAGR for the India Nano Biotechnology Market from 2025 to 2035 is 13.473%.
Pharmaceuticals holds the largest market share with a value of 100.0 million USD in 2024.
The Pharmaceuticals segment is expected to grow to 400.0 million USD by 2035.
The Medical devices segment is estimated to be valued at 70.0 million USD in 2024.
Major players include Sartorius, Intas Pharmaceuticals, Zydus Cadila, and Dr Reddy's Laboratories.
The Food and Agriculture application is expected to grow to 83.2 million USD by 2035.
The Medical research segment is valued at 50.0 million USD in 2024.
Challenges such as regulatory barriers and technological limitations may impact market growth.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
